title: Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings.
abstract: Postpartum hemorrhage due to uterine atony is the primary direct cause of maternal mortality globally. Management strategies in developed countries involve crystalloid fluid replacement, blood transfusions, and surgery. These definitive therapies are often not accessible in developing countries. Long transports from home or primary health care facilities, a dearth of skilled providers, and lack of intravenous fluids and/or a safe blood supply often create long delays in instituting appropriate treatment. We review the evidence for active management of third-stage labor and for the use of specific uterotonics. New strategies to prevent and manage postpartum hemorrhage in developing countries, such as community-based use of misoprostol, oxytocin in the Uniject delivery system, the non-inflatable antishock garment to stabilize and resuscitate hypovolemic shock, and the balloon condom catheter to treat intractable uterine bleeding are reviewed. New directions for clinical and operations research are suggested.
authors.affiliation: Women's Global Health Imperative, University of California, San Francisco, CA 94105, USA. smiller@psg.ucsf.edu
authors.forename: Suellen
authors.initials: S
authors.lastname: Miller
authors.forename: Felicia
authors.initials: F
authors.lastname: Lester
authors.forename: Paul
authors.initials: P
authors.lastname: Hensleigh
mesh_terms: D003906:Developing Countries; D004621:Embolization, Therapeutic; D005260:Female; D006700:Home Childbirth / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D008427:Maternal Health Services / Q000458:organization & administration; D008428:Maternal Mortality; D008429:Maternal Welfare; D008880:Midwifery / Q000379:methods / Q000592:standards; D016595:Misoprostol / Q000008:administration & dosage; D015402:Nursing Education Research; D010120:Oxytocics / Q000008:administration & dosage; D010121:Oxytocin / Q000008:administration & dosage; D006473:Postpartum Hemorrhage / Q000517:prevention & control* / Q000628:therapy; D011247:Pregnancy; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D018566:Pregnancy, High-Risk
chemical_list: D010120:Oxytocics; D016595:Misoprostol; D010121:Oxytocin